These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27648718)

  • 1. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
    Carrara D; Bruno RM; Bacca A; Taddei S; Duranti E; Ghiadoni L; Bernini G
    J Hypertens; 2016 Nov; 34(11):2199-205. PubMed ID: 27648718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D.
    Carrara D; Bernini M; Bacca A; Rugani I; Duranti E; Virdis A; Ghiadoni L; Taddei S; Bernini G
    J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):82-7. PubMed ID: 23283825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population.
    Zhang M; Xu X; Liu H; Li H; Zhang J; Gao M
    Clin Exp Hypertens; 2017; 39(8):685-690. PubMed ID: 28872358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang Q; Zhang M; Wang H; Sun C; Feng Y; Zhu W; Cao D; Shao Q; Li N; Xia Y; Tang T; Wan C; Liu J; Jin B; Zhao M; Jiang C
    Int Urol Nephrol; 2018 May; 50(5):923-927. PubMed ID: 29484540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls.
    Bernini G; Carrara D; Bacca A; Carli V; Virdis A; Rugani I; Duranti E; Ghiadoni L; Bernini M; Taddei S
    J Endocrinol Invest; 2013 Apr; 36(4):216-20. PubMed ID: 23645099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
    Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE
    Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin D deficiency and replacement on endothelial functions in Behçet's disease.
    Can M; Gunes M; Haliloglu OA; Haklar G; Inanç N; Yavuz DG; Direskeneli H
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S57-61. PubMed ID: 23020973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the association of vitamin D with blood pressure and the renin-angiotensin-aldosterone system in hypertensive subjects: a cross-sectional prospective study.
    Cremer A; Tambosco C; Corcuff JB; Boulestreau R; Gaillard P; Lainé M; Papaioannou G; Gosse P
    J Hum Hypertens; 2018 Feb; 32(2):114-121. PubMed ID: 29255218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.
    Levenson J; Chau NP; Billaud E; Simon A
    Am J Cardiol; 1988 May; 61(13):1056-60. PubMed ID: 2834938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial.
    McMullan CJ; Borgi L; Curhan GC; Fisher N; Forman JP
    J Hypertens; 2017 Apr; 35(4):822-829. PubMed ID: 28033130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
    Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
    Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.
    Spannella F; Giulietti F; Balietti P; Borioni E; Lombardi FE; Ricci M; Cocci G; Landi L; Sarzani R
    J Hypertens; 2017 Nov; 35(11):2315-2322. PubMed ID: 28614094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition.
    Kim MJ; Frankel AH; Donaldson M; Darch SJ; Pusey CD; Hill PD; Mayr M; Tam FW
    Kidney Int; 2011 Oct; 80(8):851-60. PubMed ID: 21832985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: The DIMENSION trial.
    Dalan R; Liew H; Assam PN; Chan ES; Siddiqui FJ; Tan AW; Chew DE; Boehm BO; Leow MK
    Diab Vasc Dis Res; 2016 May; 13(3):192-200. PubMed ID: 26818228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Vitamin D in the Treatment of Essential Hypertension.
    Legarth C; Grimm D; Wehland M; Bauer J; Krüger M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
    Nishizaka MK; Zaman MA; Green SA; Renfroe KY; Calhoun DA
    Circulation; 2004 Jun; 109(23):2857-61. PubMed ID: 15173035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial vascular function in hypertensive patients after renin-angiotensin system blockade.
    Souza-Barbosa LA; Ferreira-Melo SE; Ubaid-Girioli S; Arantes Nogueira E; Yugar-Toledo JC; Moreno H
    J Clin Hypertens (Greenwich); 2006 Nov; 8(11):803-9; quiz 810-1. PubMed ID: 17086021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.